These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31546020)

  • 1. Epigallocatechin-3-gallate (EGCG) inhibits aggregation of pulmonary fibrosis associated mutant surfactant protein A2 via a proteasomal degradation pathway.
    Quan Y; Li L; Dong L; Wang S; Jiang X; Zhang T; Jin P; Fan J; Mao S; Fan X; Gong Y; Wang Y
    Int J Biochem Cell Biol; 2019 Nov; 116():105612. PubMed ID: 31546020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical chaperone 4-phenylbutyric acid alleviates the aggregation of human familial pulmonary fibrosis-related mutant SP-A2 protein in part through effects on GRP78.
    Jiang X; Fang G; Dong L; Jin P; Ding L; Zhang H; Fan J; Mao S; Fan X; Gong Y; Wang Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3546-3557. PubMed ID: 30293573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of rat surfactant protein A have distinct effects on its glycosylation, secretion, aggregation and degradation.
    Yang W; Shen H; Fang G; Li H; Li L; Deng F; Gu W; Li K; Ma L; Gu J; Wang Y
    Life Sci; 2014 Nov; 117(2):47-55. PubMed ID: 25242514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant protein A2 mutations associated with pulmonary fibrosis lead to protein instability and endoplasmic reticulum stress.
    Maitra M; Wang Y; Gerard RD; Mendelson CR; Garcia CK
    J Biol Chem; 2010 Jul; 285(29):22103-13. PubMed ID: 20466729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human surfactant protein A2 gene mutations impair dimmer/trimer assembly leading to deficiency in protein sialylation and secretion.
    Song Y; Fang G; Shen H; Li H; Yang W; Pan B; Huang G; Lin G; Ma L; Willard B; Gu J; Zheng L; Wang Y
    PLoS One; 2012; 7(10):e46559. PubMed ID: 23056344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A green tea component suppresses posttranslational expression of basic fibroblast growth factor in colorectal cancer.
    Sukhthankar M; Yamaguchi K; Lee SH; McEntee MF; Eling TE; Hara Y; Baek SJ
    Gastroenterology; 2008 Jun; 134(7):1972-80. PubMed ID: 18549879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome dysfunction inhibits surfactant protein gene expression in lung epithelial cells: mechanism of inhibition of SP-B gene expression.
    Das A; Boggaram V
    Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L74-84. PubMed ID: 16905641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant surfactant A2 proteins associated with familial pulmonary fibrosis and lung cancer induce TGF-β1 secretion.
    Maitra M; Cano CA; Garcia CK
    Proc Natl Acad Sci U S A; 2012 Dec; 109(51):21064-9. PubMed ID: 23223528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cysteine 85 on biochemical properties and biological function of human surfactant protein A variants.
    Wang G; Myers C; Mikerov A; Floros J
    Biochemistry; 2007 Jul; 46(28):8425-35. PubMed ID: 17580966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Green tea polyphenol (-) -epigallocatechin-3-gallate promotes the rapid protein kinase C- and proteasome-mediated degradation of Bad: implications for neuroprotection.
    Kalfon L; Youdim MB; Mandel SA
    J Neurochem; 2007 Feb; 100(4):992-1002. PubMed ID: 17156130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells.
    Adachi S; Nagao T; Ingolfsson HI; Maxfield FR; Andersen OS; Kopelovich L; Weinstein IB
    Cancer Res; 2007 Jul; 67(13):6493-501. PubMed ID: 17616711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea extract and its major constituent, epigallocatechin-3-gallate, induce epithelial beta-defensin secretion and prevent beta-defensin degradation by Porphyromonas gingivalis.
    Lombardo Bedran TB; Feghali K; Zhao L; Palomari Spolidorio DM; Grenier D
    J Periodontal Res; 2014 Oct; 49(5):615-23. PubMed ID: 24206194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity.
    Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP
    J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG].
    Lam WH; Kazi A; Kuhn DJ; Chow LM; Chan AS; Dou QP; Chan TH
    Bioorg Med Chem; 2004 Nov; 12(21):5587-93. PubMed ID: 15465336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin gallate induces an up-regulation of LDL receptor accompanied by a reduction of PCSK9 via the annexin A2-independent pathway in HepG2 cells.
    Kitamura K; Okada Y; Okada K; Kawaguchi Y; Nagaoka S
    Mol Nutr Food Res; 2017 Aug; 61(8):. PubMed ID: 28181408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin Gallate Remodels Fibrils of Lattice Corneal Dystrophy Protein, Facilitating Proteolytic Degradation and Preventing Formation of Membrane-Permeabilizing Species.
    Stenvang M; Christiansen G; Otzen DE
    Biochemistry; 2016 Apr; 55(16):2344-57. PubMed ID: 27042751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of synthetic analogs of (-)-epigallocatechin-3-gallate as proteasome inhibitors.
    Kazi A; Wang Z; Kumar N; Falsetti SC; Chan TH; Dou QP
    Anticancer Res; 2004; 24(2B):943-54. PubMed ID: 15161048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin gallate promotes p53 accumulation and activity via the inhibition of MDM2-mediated p53 ubiquitination in human lung cancer cells.
    Jin L; Li C; Xu Y; Wang L; Liu J; Wang D; Hong C; Jiang Z; Ma Y; Chen Q; Yu F
    Oncol Rep; 2013 May; 29(5):1983-90. PubMed ID: 23483203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGCG antagonizes Bortezomib cytotoxicity in prostate cancer cells by an autophagic mechanism.
    Modernelli A; Naponelli V; Giovanna Troglio M; Bonacini M; Ramazzina I; Bettuzzi S; Rizzi F
    Sci Rep; 2015 Oct; 5():15270. PubMed ID: 26471237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional differences among human surfactant proteins SP-A1, SP-A2 and co-expressed SP-A1/SP-A2: role of supratrimeric oligomerization.
    Sánchez-Barbero F; Rivas G; Steinhilber W; Casals C
    Biochem J; 2007 Sep; 406(3):479-89. PubMed ID: 17542781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.